Can lumbar spine bone mineral density predict readmission in denosumab-treated patients with chronic kidney disease?

This study investigated whether bone mineral density (BMD) affects readmission risk in patients with chronic kidney diseases (CKD) who received denosumab therapy. The study design was a retrospective case review of patients with CKD. Baseline age, sex, and body mass index were recorded for all patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ben-Chung, Chen, Ying-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284349/
https://www.ncbi.nlm.nih.gov/pubmed/27581054
http://dx.doi.org/10.1136/jim-2016-000178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284349/
https://www.ncbi.nlm.nih.gov/pubmed/27581054
http://dx.doi.org/10.1136/jim-2016-000178

Ejemplares similares